| Syndrome with joint manifestations in association with Mycoplasma pneumoniae infection. | |
| | |
MedLine Citation:
|
PMID: 5662548 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Three patients experienced a rheumatic-fever-like illness with painful limitation of joint movements. The illnesses were due to infection with Mycoplasma pneumoniae. Joint symptoms have not been previously described in cases of M. pneumoniae infection. |
| | |
Authors:
|
H P Lambert |
Related Documents
:
|
3131508 - Comparative study of keratocysts, associated and non-associated with nevoid basal cell ... 1828308 - Musculoskeletal syndromes associated with acne. 995018 - Pseudohypoparathyroidism associated with cri du chat syndrome. 10233628 - Pyoderma gangrenosum complicating cogan's syndrome. 2709208 - Neuroleptic malignant syndrome in the multiple trauma patient. 19534728 - Chronic fatigue syndrome: comments on deconditioning, blood volume and resulting cardia... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British medical journal Volume: 3 ISSN: 0007-1447 ISO Abbreviation: Br Med J Publication Date: 1968 Jul |
Date Detail:
|
Created Date: 1968-09-06 Completed Date: 1968-09-06 Revised Date: 2010-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0372673 Medline TA: Br Med J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 156-7 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antibodies Antistreptolysin Arthritis / etiology Arthritis, Reactive / etiology Arthritis, Rheumatoid / etiology Child Complement Fixation Tests Female Humans Joint Diseases / etiology* Lupus Erythematosus, Systemic / etiology Male Mycoplasma Infections / complications* Rheumatic Fever / diagnosis* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies; 9006-92-2/Antistreptolysin |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lead poisoning in blind children.
Next Document: Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure.